| Year |
Citation |
Score |
| 2005 |
Luger NM, Mach DB, Sevcik MA, Mantyh PW. Bone cancer pain: from model to mechanism to therapy. Journal of Pain and Symptom Management. 29: S32-46. PMID 15907645 DOI: 10.1016/J.Jpainsymman.2005.01.008 |
0.834 |
|
| 2005 |
Peters CM, Ghilardi JR, Keyser CP, Kubota K, Lindsay TH, Luger NM, Mach DB, Schwei MJ, Sevcik MA, Mantyh PW. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Experimental Neurology. 193: 85-100. PMID 15817267 DOI: 10.1016/J.Expneurol.2004.11.028 |
0.812 |
|
| 2004 |
Sevcik MA, Luger NM, Mach DB, Sabino MA, Peters CM, Ghilardi JR, Schwei MJ, Röhrich H, De Felipe C, Kuskowski MA, Mantyh PW. Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis. Pain. 111: 169-80. PMID 15327821 DOI: 10.1016/J.Pain.2004.06.015 |
0.816 |
|
| 2004 |
Sabino M, Luger N, Keyser C, Schwei M, Mach D, Sevcik M, Peters C, Mantyh P. Tumor-induced injury of sensory nerve fibers in bone cancer pain Journal of Oral and Maxillofacial Surgery. 62: 21-22. DOI: 10.1016/J.Joms.2004.05.143 |
0.555 |
|
| 2003 |
Sabino MA, Luger NM, Mach DB, Rogers SD, Schwei MJ, Mantyh PW. Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system. International Journal of Cancer. Journal International Du Cancer. 104: 550-8. PMID 12594809 DOI: 10.1002/Ijc.10999 |
0.824 |
|
| 2002 |
Sabino MC, Ghilardi JR, Feia KJ, Jongen JL, Keyser CP, Luger NM, Mach DB, Peters CM, Rogers SD, Schwei MJ, De Filipe C, Mantyh PW. The involvement of prostaglandins in tumorigenesis, tumor-induced osteolysis and bone cancer pain. Journal of Musculoskeletal & Neuronal Interactions. 2: 561-2. PMID 15758394 |
0.828 |
|
| 2002 |
Sabino MA, Ghilardi JR, Jongen JL, Keyser CP, Luger NM, Mach DB, Peters CM, Rogers SD, Schwei MJ, de Felipe C, Mantyh PW. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Research. 62: 7343-9. PMID 12499278 |
0.832 |
|
| 2002 |
Luger NM, Sabino MA, Schwei MJ, Mach DB, Pomonis JD, Keyser CP, Rathbun M, Clohisy DR, Honore P, Yaksh TL, Mantyh PW. Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain. 99: 397-406. PMID 12406514 DOI: 10.1016/S0304-3959(02)00102-1 |
0.816 |
|
| 2002 |
Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, Pomonis JD, Keyser CP, Clohisy DR, Adams DJ, O'Leary P, Mantyh PW. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience. 113: 155-66. PMID 12123694 DOI: 10.1016/S0306-4522(02)00165-3 |
0.738 |
|
| 2002 |
Sabino MA, Honore P, Rogers SD, Mach DB, Luger NM, Mantyh PW. Tooth extraction-induced internalization of the substance P receptor in trigeminal nucleus and spinal cord neurons: imaging the neurochemistry of dental pain. Pain. 95: 175-86. PMID 11790480 DOI: 10.1016/S0304-3959(01)00397-9 |
0.713 |
|
| 2001 |
Luger NM, Honore P, Sabino MA, Schwei MJ, Rogers SD, Mach DB, Clohisy DR, Mantyh PW. Osteoprotegerin diminishes advanced bone cancer pain. Cancer Research. 61: 4038-47. PMID 11358823 |
0.832 |
|
| 2000 |
Honore P, Luger NM, Sabino MA, Schwei MJ, Rogers SD, Mach DB, O'keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nature Medicine. 6: 521-8. PMID 10802707 DOI: 10.1038/74999 |
0.826 |
|
| Show low-probability matches. |